Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy - PubMed (original) (raw)
. 1999 Mar 26;274(13):8806-12.
doi: 10.1074/jbc.274.13.8806.
Affiliations
- PMID: 10085122
- DOI: 10.1074/jbc.274.13.8806
Free article
Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy
F Yanaga et al. J Biol Chem. 1999.
Free article
Abstract
Human wild-type cardiac troponin T, I, C and five troponin T mutants (I79N, R92Q, F110I, E244D, and R278C) causing familial hypertrophic cardiomyopathy were expressed in Escherichia coli, and then were purified and incorporated into rabbit cardiac myofibrils using a troponin exchange technique. The Ca2+-sensitive ATPase activity of these myofibrillar preparations was measured in order to examine the functional consequences of these troponin mutations. An I79N troponin T mutation was found to cause a definite increase in Ca2+ sensitivity of the myofibrillar ATPase activity without inducing any significant change in the maximum level of ATPase activity. A detailed analysis indicated the inhibitory action of troponin I to be impaired by the I79N troponin T mutation. Two more troponin T mutations (R92Q and R278C) were also found to have a Ca2+-sensitizing effect without inducing any change in maximum ATPase activity. Two other troponin T mutations (F110I and E244D) had no Ca2+-sensitizing effects on the ATPase activity, but remarkably potentiated the maximum level of ATPase activity. These findings indicate that hypertrophic cardiomyopathy-linked troponin T mutations have at least two different effects on the Ca2+-sensitive ATPase activity, Ca2+-sensitization and potentiation of the maximum level of the ATPase activity.
Similar articles
- Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T.
Harada K, Takahashi-Yanaga F, Minakami R, Morimoto S, Ohtsuki I. Harada K, et al. J Biochem. 2000 Feb;127(2):263-8. doi: 10.1093/oxfordjournals.jbchem.a022603. J Biochem. 2000. PMID: 10731693 - Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
Szczesna D, Zhang R, Zhao J, Jones M, Guzman G, Potter JD. Szczesna D, et al. J Biol Chem. 2000 Jan 7;275(1):624-30. doi: 10.1074/jbc.275.1.624. J Biol Chem. 2000. PMID: 10617660 - F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
Hernandez OM, Szczesna-Cordary D, Knollmann BC, Miller T, Bell M, Zhao J, Sirenko SG, Diaz Z, Guzman G, Xu Y, Wang Y, Kerrick WG, Potter JD. Hernandez OM, et al. J Biol Chem. 2005 Nov 4;280(44):37183-94. doi: 10.1074/jbc.M508114200. Epub 2005 Aug 22. J Biol Chem. 2005. PMID: 16115869 - Molecular mechanisms of cardiac myofilament activation: modulation by pH and a troponin T mutant R92Q.
Solaro RJ, Varghese J, Marian AJ, Chandra M. Solaro RJ, et al. Basic Res Cardiol. 2002;97 Suppl 1:I102-10. doi: 10.1007/s003950200038. Basic Res Cardiol. 2002. PMID: 12479243 Review. - Molecular genetic studies of familial hypertrophic cardiomyopathy.
Seidman CE, Seidman JG. Seidman CE, et al. Basic Res Cardiol. 1998;93 Suppl 3:13-6. doi: 10.1007/s003950050196. Basic Res Cardiol. 1998. PMID: 9879437 Review.
Cited by
- Inherited cardiomyopathies caused by troponin mutations.
Lu QW, Wu XY, Morimoto S. Lu QW, et al. J Geriatr Cardiol. 2013 Mar;10(1):91-101. doi: 10.3969/j.issn.1671-5411.2013.01.014. J Geriatr Cardiol. 2013. PMID: 23610579 Free PMC article. - Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy.
Matsumoto Y, Hayashi T, Inagaki N, Takahashi M, Hiroi S, Nakamura T, Arimura T, Nakamura K, Ashizawa N, Yasunami M, Ohe T, Yano K, Kimura A. Matsumoto Y, et al. J Muscle Res Cell Motil. 2005;26(6-8):367-74. doi: 10.1007/s10974-005-9018-5. J Muscle Res Cell Motil. 2005. PMID: 16465475 - The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K, Tinney JP, Moskowitz IP, Perez-Atayde AR, Keller BB, Mathier MA, Shroff SG, Seidman CE, Seidman JG. Ahmad F, et al. PLoS One. 2008 Jul 9;3(7):e2642. doi: 10.1371/journal.pone.0002642. PLoS One. 2008. PMID: 18612386 Free PMC article. - TNNT1, TNNT2, and TNNT3: Isoform genes, regulation, and structure-function relationships.
Wei B, Jin JP. Wei B, et al. Gene. 2016 May 10;582(1):1-13. doi: 10.1016/j.gene.2016.01.006. Epub 2016 Jan 13. Gene. 2016. PMID: 26774798 Free PMC article. Review. - Hypertrophic cardiomyopathy: from genetics to treatment.
Marian AJ. Marian AJ. Eur J Clin Invest. 2010 Apr;40(4):360-9. doi: 10.1111/j.1365-2362.2010.02268.x. Eur J Clin Invest. 2010. PMID: 20503496 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous